Athira Pharma to Participate in Upcoming October Conferences
28 Setembro 2023 - 8:00AM
Athira Pharma, Inc. (NASDAQ: ATHA), a late clinical-stage
biopharmaceutical company focused on developing small molecules to
restore neuronal health and slow neurodegeneration, today announced
that Company management will participate in the following upcoming
investor conferences in October.
Goldman Sachs Alzheimer’s Disease DayFormat:
Panel Presentation Date and Time: Tuesday, October 3, 2023, from
10:00 a.m. ET- 11:00 a.m. ET Location: Goldman Sachs Conference
Center, New York City
JonesTrading 2023 Healthcare SummitFormat:
Investor MeetingsInvestors interested in meeting with Athira
management during the JonesTrading Conference, please reach out to
your JonesTrading representative or contact Julie Rathbun at
julie.rathbun@athira.com.Dates: October 9-11 Location: Eden Roc,
Miami
Jefferies Inaugural Biotech CNS/Neuro Summit
Format: Fireside ChatDate and Time: Thursday, October 12, 2023, at
8:30 a.m. ETLocation: Jefferies Conference Center, New York
City
Live webcasts of the panel and presentations can be accessed
from the Investors section of the Athira website at
https://investors.athira.com/news-and-events/events-and-presentations-investor. An
archived replay of the webcasts will be available for at least 30
days following the event.
About Athira Pharma, Inc.Athira Pharma, Inc.,
headquartered in the Seattle, Washington area, is a late
clinical-stage biopharmaceutical company focused on developing
small molecules to restore neuronal health and slow
neurodegeneration. Athira aims to alter the course of neurological
disease by advancing its pipeline of therapeutic candidates
targeting the neurotrophic HGF system for Alzheimer’s and
Parkinson’s disease, Dementia with Lewy bodies, and amyotrophic
lateral sclerosis. For more information, visit www.athira.com. You
can also follow Athira on Facebook, LinkedIn, X (formerly known as
Twitter) and Instagram.
Investor & Media Contact:
Julie RathbunAthira
PharmaJulie.rathbun@athira.com206-769-9219
Athira Pharma (NASDAQ:ATHA)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
Athira Pharma (NASDAQ:ATHA)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024